摘要
目的分析个体化生活方式干预对2型糖尿病(T2DM)患者依从性的评价,探讨其对控制T2DM患者代谢状况的效果。方法T2DM患者200例,随机分为实验组和对照组各100例。试验组在原口服药基础上给予个体化生活方式干预6个月,即根据患者病情开具饮食控制处方和运动治疗处方;对照组在原口服药基础上给予常规的、口头上的生活方式干预6个月。比较两组生活方式干预患者的依从性及各种代谢指标的变化。结果试验组饮食控制,运动疗法执行者所占比率均高于对照组(饮食控制:80例与52例,x2=7.08,P=0.029;运动疗法:78例与44例,x2=11.207,P=0.004)。干预后,试验组空腹血糖(FPG)、餐后2h血糖(2hPG)、糖化血红蛋白(HbAlc)、体质量指数(BMI)、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL—C)及胰岛素抵抗指数(HOMA-IR)均明显下降,高密度脂蛋白胆固醇(HDL—c)显著增高[干预前后分别为:FPG:(8.45±1.46)mmol/L与(6.66±0.67)mmol/L,P=0.000;2hPG:(12.76±2.25)mmol/L与(8.22±1.79)mmol/L,P=0.000;HbAlc:(7.68±1.06)%与(6.48±0.69)%,P=0.000;BMI:(25.90±1.72)kg/m2与(22.81±1.41)kg/113。,P=0.016;TG:(2.57±0.68)mmol/L与(1.88±0.35)mmol/L,P=0.006;TC:(5.72±0.13)mmol/L与(5.14±1.38)retool/L,P=0.043;LDL—C:(3.28±0.10)mmol/L与(2.81±0.57)mmol/L,P=0.009;HOMA—IR:7.58±0.19与4.58±1.98,P=0.000;HDL-C:(1.29±0.04)mmol/L与(1.62±0.27)mmol/L,P=0.003)],对照组FPG、2hPG、HbAlc、BMI、TG、HoMA—IR亦有所下降[干预前后分别为:FPG:(8.67±2.71)mmol/L与(7.26±1.21)mmol/L。P=0.001;2hPG:(12.82±2.15)mmol/L与(10.85±1.98)mmol/L,P=0.000,HbAlc:(7.75±1.08)%与(7.01±0.87)%,P=0.002;BMI:(25.82±1.74)kg/mz与(24.23±1.36)kg/m2.P=0.024;TG:(2.47±0.75)mmol/L与(2.13±0.43)mmol/L,P=0.018;HOMA.11±7.88±0.20与6.15±2.01,P=0.042)],但TC、HDL-C、LDL.C与干预前比较差异均无统计学意义(P均〉0.05)。干预后两组FPG、2hPG、HbAlc、BMI、TG、HoMA—IR比较,试验组效果更明显[P值分别为:0.036、0.000、0.045、0.037、0.022、0.000)]。结论个体化生活方式干预可提高糖尿病(DM)患者依从性,有利于控制糖尿病患者的代谢状况,延缓并发症的发生和发展。
Objective To analyze the effects of individualized lifestyle intervention on compliance and' metabolic status of patients with type 2 diabetes mellitus (T2DM). Methods Two hundred T2DM patients were selected and randomly divided into experimental and control groups of 100 patients respectively. The experimental group was given individualized lifestyle intervention for 6 months in addition to conventional oral medications. The intervention was to prescribe diet control and exercise therapy according to the patients' individual conditions. The control group was given conventional treatment and verbal lifestyle intervention for 6 months. Comparison was made in patients compliance and various metabolic markers between the two groups. Results The percentage of conduction of diet control and exercise therapy in experimental group was significantly higher than control group ( Diet control : 80 vs. 52, X2 = 7. 08, P = 0. 029 ; Exercise therapy : 78 vs. 44, ~2 = 11. 207, P = 0. 004). After intervention, the fasting plasma glucose (FPG) ,2-hour postprandial blood glucose (2hPG), glycated hemoglobin ( HbA1 e ), body mass index ( BMI ), triglyeeride ( TG), total cholesterol (TC), low-density lipoprotein (LDL-C), and insulin resistance index (HOMA-IR) in experimental group decreased significantly, and high-density lipoprotein ( HDL-C ) increased significantly [ FPG : ( 8.45±1.46 ) mmol/L vs. ( 6. 66±0.67 ) mmol/L, P = 0. 000 ;2hPG : ( 12. 76±2. 25 ) mmol/L vs. ( 8.22±1.79 ) mmol/L, P =0. 000 ; HbA1 c : ( 7.68±1.06 ) % vs. ( 6.48±0. 69 ) %, P = 0. 000 ; BMI : ( 25.90±1.72 ) kg/m/ vs. ( 22. 81±1.41) kg/m2,P =0. 016;TG: (2. 57±0. 68) mmol/Lvs. ( 1.88 ±0. 35) mmol/L,P =0. 006;TC : (5.72±0. 13) mmol/L vs. (5.14±1.38) mmol/L,P =0. 043 ;LDL-C. (3.28 ±0. 10) mmol/L vs. (2. 81±0. 57) mmol/L,P = 0. 009 ; HOMA-IR :7. 58 ±0. 19 vs. 4. 58± 1.98,P = 0. 000 ; HDL-C : ( 1.29±0. 04) mmol/L vs. ( 1.62 ± 0. 27 ) mmolfL,P = 0. 0031. The levels of FPG, 2hPG, HbAlc, BMI, TG, HOMA-IR also decreased in control group after intervention compared with before intervention [ FPG: ( 8.67 ± 2. 71 ) mmol/L vs. ( 7. 26 ± 1.21 ) mmol/L, P = 0. 001 ;2hPG: ( 12. 82 ± 2. 15 ) mmol/L vs. ( 10. 85± 1.98 ) mmol/L, P = 0. 000, HbA1 e : ( 7. 75 ± 1.08 ) % vs. (7.01 ±0.87)% ,P =0.002;BMI: (25.82± 1.74) kg/m2 vs. (24.23 ±1.36) kg/m2,P = 0. 024;TG: (2.47 ±0.75 ) mmol/L vs. ( 2. 13 ± 0. 43 ) mmol/L, P = 0. 018 ; HoMA-IR : 7.88 ± 0. 20 vs. 6. 15 ± 2. 01, P = 0. 042 ]. No significant difference was found on the values of TC, HDL-C and LDL-C before and after intervention in control group ( P 〉 0. 05 ). The effect of intervention of experimental group was more obvious when compared with control group ( FPG : P = 0. 036 ; 2hPG : P = 0. 000 ; HbA1 c : P = 0. 045 ; BMI : P = 0. 037 ; TG : P = 0. 022 ; HoMA-IR:P =0. 000). Conclusion Individualized lifestyle intervention can improve the compliance of T2DM patients, and was in favor of control metabolic status of T2DM patients to delay the occurrence and development of complications.
出处
《中国综合临床》
2012年第12期1310-1314,共5页
Clinical Medicine of China
关键词
个体化生活方式干预
2型糖尿病
依从性
代谢状况
Individualized lifestyle intervention
Type 2 diabetes mellitus
Compliance
Metabolic status